PolyPeptide Group AG (SWX:PPGN)

Switzerland · Delayed Price · Currency is CHF

29.80

+0.10 (0.34%)

Apr 2, 2026, 5:30 PM CET

Revenue by Segment

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Development	153.43M	118.15M	154.45M	140.04M	167.01M
Development Growth	29.86%	-23.51%	10.29%	-16.14%	63.94%
Commercial	235.90M	218.64M	-	-	-
Commercial Growth	7.89%	-	-	-	-
Contract Manufacturing	-	-	135.39M	110.75M	89.60M
Contract Manufacturing Growth	-	-	22.24%	23.61%	-10.50%
Generics and Cosmetics	-	-	30.53M	30.18M	25.52M
Generics and Cosmetics Growth	-	-	1.17%	18.26%	21.22%
Total	389.33M	336.79M	320.37M	280.98M	282.13M
Total Growth	15.60%	5.13%	14.02%	-0.41%	26.50%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
USA	98.08M	94.42M	92.76M	90.16M	89.89M
USA Growth	3.88%	1.79%	2.89%	0.30%	26.61%
Europe & India	291.24M	242.37M	227.61M	-	-
Europe & India Growth	20.16%	6.49%	-	-	-
Europe & Asia	-	-	-	190.82M	192.24M
Europe & Asia Growth	-	-	-	-0.74%	26.44%
Total	389.33M	336.79M	320.37M	280.98M	282.13M
Total Growth	15.60%	5.13%	14.02%	-0.41%	26.50%

Source: S&P Global Market Intelligence.